Search by Drug Name or NDC
NDC 99207-0240-05 Calcium Disodium Versenate 200 mg/mL Details
Calcium Disodium Versenate 200 mg/mL
Calcium Disodium Versenate is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch Health Us, LLC. The primary component is EDETATE CALCIUM DISODIUM.
Product Information
| NDC | 99207-0240 |
|---|---|
| Product ID | 99207-240_c3e61446-06de-4a15-8a6a-830fa6e8b2ff |
| Associated GPIs | 93000040002020 |
| GCN Sequence Number | 002545 |
| GCN Sequence Number Description | edetate calcium disodium AMPUL 200 MG/ML INJECTION |
| HIC3 | C8C |
| HIC3 Description | LEAD POISONING, AGENTS TO TREAT (CHELATING-TYPE) |
| GCN | 07132 |
| HICL Sequence Number | 001105 |
| HICL Sequence Number Description | EDETATE CALCIUM DISODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Calcium Disodium Versenate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | EDETATE CALCIUM DISODIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/mL |
| Substance Name | EDETATE CALCIUM DISODIUM |
| Labeler Name | Bausch Health Us, LLC |
| Pharmaceutical Class | Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Decreased Coagulation Factor Activity [PE], Lead Chelating Activity [MoA], Lead Chelator [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA008922 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 99207-0240-05 (99207024005)
| NDC Package Code | 99207-240-05 |
|---|---|
| Billing NDC | 99207024005 |
| Package | 5 AMPULE in 1 CARTON (99207-240-05) / 5 mL in 1 AMPULE |
| Marketing Start Date | 2016-06-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |